Javing, Jewel Lizette .
HRN: 24-48-88 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/05/2024
AMPICILLIN 1GM (VIAL)
08/05/2024
08/12/2024
IV
2g
Q6
PPH Sec To Retained Placental Fragments
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes